- From: Peter Crowther <Peter.Crowther@networkinference.com>
- Date: Wed, 29 Jan 2003 16:20:57 -0000
- To: <www-rdf-logic@w3.org>
Hope this isn't too commercial for this list :-). - Peter -- snip -- myGRID SELECTS NETWORK INFERENCE'S CEREBRA INFERENCE ENGINE TO DRIVE PROJECT Life sciences effort breaks new ground with creation of an open grid service architecture London - 29 January 2003 - e-Science research project, myGrid, has selected Network Inference as an industrial partner to provide its Cerebra Inference Engine to drive the development of a new open grid service architecture, producing a virtual laboratory workbench for the life sciences community. The architecture will create a collaborative and supportive environment that allows geographically distributed scientists to implement long-term research projects using complex distributed resources. The Cerebra Inference Engine will enable the grid to process data based on semantics, allowing the scientists to identify the available resources and services in their field. This will provide for a dynamic environment where resources can be exchanged to maintain the integrity of the workbench as new resources become available or existing resources become redundant. Commenting on the use of the Cerebra Inference Engine, Professor Carole Goble, University of Manchester, says: "The Cerebra Inference Engine's ability to identify services and organise them into classifications through very rich descriptions and to give meaning to these descriptions is impressive. This technology means we are able to scale our solutions and better able to meet the stringent performance criteria of a virtual laboratory workbench." Jon Matonis, CEO, Network Inference, added: "The myGrid project is a great opportunity for the life sciences world to experience the very real benefits that Network Inference can bring to this community. The Cerebra Inference Engine is ideal for improving the speed and quality of pharmaceutical and life science research including drug discovery, gene research, and bio-medical informatics. " More...The particular focus of myGrid is on data-intensive e-Science and the provision of a distributed environment that supports the in silico experimental process - enabling clients to seamlessly link together databases and analytical tools using process flows, extract relevant information from free texts, and harness available computational resources for CPU-intensive tasks. MyGrid's industrial collaborators include AstraZeneca (London: AZN), GlaxoSmithKline (London:GSK), GeneticXchange, Merck KgaA (NYSE:MRK), SUN Microsystems (Nasdaq: SUNW), IBM (NYSE: IBM), and Epistemics Ltd. - ends - Note for editors: myGrid The myGrid project is an EPSRC-funded collaboration between the University of Manchester (UK), the University of Newcastle (UK), the University of Nottingham (UK), the University of Sheffield (UK), the University of Southampton (UK), IT-Innovation (UK), and EMBL European Bioinformatics Institute. Industrial collaborators include: AstraZeneca, GlaxoSmithKline, GeneticXchange, Merck KGaA, SUN Microsystems, IBM, Epistemics Ltd., and Network Inference. Network Inference Network Inference develops and sells software that allows applications, across the extended enterprise, to share data through semantic integration, providing a shared frame of reference for computers to communicate with each other. The company's Cerebra product portfolio is based on technology resulting from 13 years of research at the University of Manchester. Network Inference is backed by Nokia Venture Partners and is based in London, England with a subsidiary in the US. For more information visit: www.networkinference.com. For more information please contact: Kate Hartley/Malini Majithia Carrot Communications Tel: +44 20 7953 4010 e-mail: kate.hartley@carrotcomms.co.uk or malini.majithia@carrotcomms.co.uk
Received on Wednesday, 29 January 2003 11:22:24 UTC